BlossomHill Therapeutics, Inc.

Pharmaceutical company · San Diego, California, United States · Nasdaq: BLSM

BlossomHill Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker BLSM. It has reported private securities offerings to the US SEC, most recently $84 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

BlossomHill Therapeutics at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Earliest incorporation on record2020
Stock listingNasdaq: BLSM
SEC industryPharmaceutical Preparations
SEC CIK1839970

What does BlossomHill Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $84.2 million sold (2025).

Frequently asked questions about BlossomHill Therapeutics

Where is BlossomHill Therapeutics headquartered?

BlossomHill Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does BlossomHill Therapeutics do?

BlossomHill Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is BlossomHill Therapeutics a public company?

Yes. BlossomHill Therapeutics, Inc. trades on Nasdaq under the ticker BLSM.

When was BlossomHill Therapeutics founded?

The earliest incorporation on record for BlossomHill Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.